Increase Tolerance for Exercise and Raise Activity Through Connectedness Trial (INTERACT)
Primary Purpose
Cystic Fibrosis
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Fitbit
Sponsored by
About this trial
This is an interventional treatment trial for Cystic Fibrosis focused on measuring Cystic Fibrosis, Exercise, Fitbit
Eligibility Criteria
Inclusion Criteria:
- A diagnosis of Cystic Fibrosis
- Age 18 and over
- Must be able to complete at least level 1 of the baseline exercise fitness test
- Must not have required IV antibiotics for a CF exacerbation within 30 days of starting the program
Exclusion Criteria:
- Pregnancy at enrollment
- A history of CF exacerbation requiring IV antibiotics within last month
- Use of a fitness tracker or similar product within 6 months of enrollment
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Fitbit
Usual Care
Arm Description
Participants receive a Fitbit and are followed over the course of one year, completing surveys and exercise tests.
Participants receive usual care over the course of one year and are offered a Fitbit in the second year. Followed to assess use of Fitbit and health outcomes.
Outcomes
Primary Outcome Measures
Graded exercise test (Submaximal GXT)
Change is submaximal GXT will be assessed for all participants
Secondary Outcome Measures
Fitbit activity data
HAES (Habitual Activity Estimation Scale)
Relative change from baseline in ppFEV1
Forced Expiratory Volume in one second (FEV1) from before study (Baseline) to each data collection timepoint, and from one data collection timepoint to the next.
Relative change from baseline in ppFVC
Forced Vital Capacity in one second (FVC) from before study (Baseline) to each data collection timepoint, and from one data collection timepoint to the next.
Relative change from baseline in ppFEF25-75
Forced Expiratory Flow in one second (FEF25-75) from before study (Baseline) to each data collection timepoint, and from one data collection timepoint to the next.
Incidence of exacerbations requiring IV antibiotics
BMI
CFQ-R (Survey on Quality of Life in Cystic Fibrosis)
Overall qualitative assessment of participant satisfaction with the Fitbit
Qualitative data obtained by open-ended interview
Overall qualitative assessment of participant's potential barriers to Fitbit use
Qualitative data obtained by open-ended interview
Overall qualitative assessment of the participant's use of the social media associated with the device
Qualitative data obtained by open-ended interview
PHQ9
Depression scale scored 0-27, with a score of 0-4 indicating minimal risk for depression/anxiety, a score of 5-9 indicating mild risk for depression/anxiety, a score of 10-14 indicating moderate risk for depression/anxiety, and a score if 15-27 indicating severe risk for depression/anxiety.
GAD-7
Depression scale scored 0-21, with a score of 0-4 indicating minimal risk for depression/anxiety, a score of 5-9 indicating mild risk for depression/anxiety, a score of 10-14 indicating moderate risk for depression/anxiety, and a score if 15-21 indicating severe risk for depression/anxiety.
Full Information
NCT ID
NCT02700243
First Posted
February 21, 2016
Last Updated
June 7, 2021
Sponsor
Boston Children's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02700243
Brief Title
Increase Tolerance for Exercise and Raise Activity Through Connectedness Trial
Acronym
INTERACT
Official Title
Pilot RCT Study Using a Fitbit Device to Improve Exercise Tolerance in 80 Patients With Cystic Fibrosis
Study Type
Interventional
2. Study Status
Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
March 14, 2016 (Actual)
Primary Completion Date
April 2019 (Actual)
Study Completion Date
April 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston Children's Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
In this research study the investigators want to learn more about whether using a fitness tracker and accelerometer helps patients with cystic fibrosis exercise more regularly, and in turn whether it increases exercise tolerance over the period of one year.
Detailed Description
The aim of this study is to evaluate whether the use of a Fitbit device and an exercise prescription is associated with increased daily activity and in turn increased exercise tolerance in young adult patients with cystic fibrosis (CF). The investigators hypothesize that use of the Fitbit and an exercise prescription will be associated with increased exercise tolerance compared to standard counseling and an exercise prescription alone.
For patients with CF, young adulthood and adolescence is a significant time of vulnerability. In addition to normal behavioral challenges of adolescence and young adulthood (seeking independence/autonomy while also choosing rebellion), those with CF are often dealing with significant disease progression. Therefore, working in new innovative ways to improve adherence to regimens that improve lung function such as exercise are needed to continue to support patients during this vulnerable time.
Studies of patients with cystic fibrosis have shown that regular exercise training can decrease rate of lung function decline, potentially improve lung function, and improve aerobic capacity. However, many patients do not include regular exercise in their daily routine. Successful strategies to improve adherence include providing patient specific guidelines for an appropriate exercise program, supporting participation and providing positive feedback. Overall, exercise is a crucial diagnostic and therapeutic modality for patients with Cystic Fibrosis, although awareness somewhat limited. The adult CF program at Boston Children's and Brigham & Women's Hospital established an inpatient and outpatient exercise program as part of a quality improvement effort. Patients are prescribed an individualized exercise program or exercise prescription based on their assessment during a sub-maximal effort. This program has been successful but given the rigors of daily life (e.g. school, work, family obligations), adherence is a concern with resources limiting more rigorous feedback to maintain this essential life activity.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
Keywords
Cystic Fibrosis, Exercise, Fitbit
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Fitbit
Arm Type
Experimental
Arm Description
Participants receive a Fitbit and are followed over the course of one year, completing surveys and exercise tests.
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Participants receive usual care over the course of one year and are offered a Fitbit in the second year. Followed to assess use of Fitbit and health outcomes.
Intervention Type
Behavioral
Intervention Name(s)
Fitbit
Intervention Description
Participants receive a Fitbit and are followed over the course of one year to determine use and health outcomes.
Primary Outcome Measure Information:
Title
Graded exercise test (Submaximal GXT)
Description
Change is submaximal GXT will be assessed for all participants
Time Frame
Two years (Enrollment, 6 months, 12 months, 24 months)
Secondary Outcome Measure Information:
Title
Fitbit activity data
Time Frame
Two years
Title
HAES (Habitual Activity Estimation Scale)
Time Frame
Two years
Title
Relative change from baseline in ppFEV1
Description
Forced Expiratory Volume in one second (FEV1) from before study (Baseline) to each data collection timepoint, and from one data collection timepoint to the next.
Time Frame
Two years
Title
Relative change from baseline in ppFVC
Description
Forced Vital Capacity in one second (FVC) from before study (Baseline) to each data collection timepoint, and from one data collection timepoint to the next.
Time Frame
Two years
Title
Relative change from baseline in ppFEF25-75
Description
Forced Expiratory Flow in one second (FEF25-75) from before study (Baseline) to each data collection timepoint, and from one data collection timepoint to the next.
Time Frame
Two years
Title
Incidence of exacerbations requiring IV antibiotics
Time Frame
Two years
Title
BMI
Time Frame
Two years
Title
CFQ-R (Survey on Quality of Life in Cystic Fibrosis)
Time Frame
Two years
Title
Overall qualitative assessment of participant satisfaction with the Fitbit
Description
Qualitative data obtained by open-ended interview
Time Frame
Two years (6 Month Time Point)
Title
Overall qualitative assessment of participant's potential barriers to Fitbit use
Description
Qualitative data obtained by open-ended interview
Time Frame
Two years (6 Month Time Point)
Title
Overall qualitative assessment of the participant's use of the social media associated with the device
Description
Qualitative data obtained by open-ended interview
Time Frame
Two years (6 Month Time Point)
Title
PHQ9
Description
Depression scale scored 0-27, with a score of 0-4 indicating minimal risk for depression/anxiety, a score of 5-9 indicating mild risk for depression/anxiety, a score of 10-14 indicating moderate risk for depression/anxiety, and a score if 15-27 indicating severe risk for depression/anxiety.
Time Frame
Two years (Enrollment, 6 months, 12 months, 18 months, 24 months)
Title
GAD-7
Description
Depression scale scored 0-21, with a score of 0-4 indicating minimal risk for depression/anxiety, a score of 5-9 indicating mild risk for depression/anxiety, a score of 10-14 indicating moderate risk for depression/anxiety, and a score if 15-21 indicating severe risk for depression/anxiety.
Time Frame
Two years (Enrollment, 6 months, 12 months, 18 months, 24 months)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
A diagnosis of Cystic Fibrosis
Age 18 and over
Must be able to complete at least level 1 of the baseline exercise fitness test
Must not have required IV antibiotics for a CF exacerbation within 30 days of starting the program
Exclusion Criteria:
Pregnancy at enrollment
A history of CF exacerbation requiring IV antibiotics within last month
Use of a fitness tracker or similar product within 6 months of enrollment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ahmet Uluer, DO
Organizational Affiliation
Boston Children's Hospital
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Participants will receive their graded exercise test scores as part of their clinical care and will be able to see their individual data relating to Fitbit on their own device.
Learn more about this trial
Increase Tolerance for Exercise and Raise Activity Through Connectedness Trial
We'll reach out to this number within 24 hrs